The Farnesoid X Receptor as a Master Regulator of Hepatotoxicity

被引:12
作者
Rausch, Magdalena [1 ]
Samodelov, Sophia L. [1 ]
Visentin, Michele [1 ]
Kullak-Ublick, Gerd A. [1 ]
机构
[1] Univ Zurich, Univ Hosp Zurich, Dept Clin Pharmacol & Toxicol, CH-8006 Zurich, Switzerland
基金
瑞士国家科学基金会;
关键词
drug-induced liver injury; farnesoid X receptor (FXR); hepatotoxicity; inflammation; liver; NAFLD and NASH; SALT EXPORT PUMP; MULTIDRUG-RESISTANCE PROTEIN-3; INDUCED HEPATIC STEATOSIS; BILE-ACID SYNTHESIS; NUCLEAR RECEPTOR; FATTY LIVER; OBETICHOLIC ACID; UP-REGULATION; NONALCOHOLIC STEATOHEPATITIS; TRANSCRIPTIONAL REGULATION;
D O I
10.3390/ijms232213967
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The nuclear receptor farnesoid X receptor (FXR, NR1H4) is a bile acid (BA) sensor that links the enterohepatic circuit that regulates BA metabolism and elimination to systemic lipid homeostasis. Furthermore, FXR represents a real guardian of the hepatic function, preserving, in a multifactorial fashion, the integrity and function of hepatocytes from chronic and acute insults. This review summarizes how FXR modulates the expression of pathway-specific as well as polyspecific transporters and enzymes, thereby acting at the interface of BA, lipid and drug metabolism, and influencing the onset and progression of hepatotoxicity of varying etiopathogeneses. Furthermore, this review article provides an overview of the advances and the clinical development of FXR agonists in the treatment of liver diseases.
引用
收藏
页数:19
相关论文
共 50 条
  • [21] Medicinal Chemistry and Pharmacological Effects of Farnesoid X Receptor (FXR) Antagonists
    Lamers, Christina
    Schubert-Zsilavecz, Manfred
    Merk, Daniel
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2014, 14 (19) : 2188 - 2205
  • [22] A Short Review on Obeticholic Acid: An Effective Modulator of Farnesoid X Receptor
    Narayanan, Anila Kutty
    Surendran, Sudhindran
    Balakrishnan, Dinesh
    Gopalakrishnan, Unnikrishnan
    Malick, Shweta
    Valsan, Arun
    Philips, Abby Cyriac
    Watson, Christopher
    CURRENT REVIEWS IN CLINICAL AND EXPERIMENTAL PHARMACOLOGY, 2024, 19 (03) : 225 - 233
  • [23] Patented Farnesoid X receptor modulators: a review (2019-present)
    Gioiello, Antimo
    Rosatelli, Emiliano
    Cerra, Bruno
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2024, 34 (07) : 547 - 564
  • [24] Discovery of a novel and orally active Farnesoid X receptor agonist for the protection of acetaminophen-induced hepatotoxicity
    Cai, Zongyu
    Wang, Bin
    Zhou, Zongtao
    Zhao, Xin
    Hu, Lijun
    Ren, Qiang
    Deng, Liming
    Li, Zheng
    Wang, Guangji
    CHEMICAL BIOLOGY & DRUG DESIGN, 2022, 99 (03) : 483 - 495
  • [25] Farnesoid X Receptor an Emerging Target to Combat Obesity
    Filho, C. Daniel De Magalhaes
    Downes, Michael
    Evans, Ronald M.
    DIGESTIVE DISEASES, 2017, 35 (03) : 185 - 190
  • [26] Farnesoid X receptor activation inhibits pancreatic carcinogenesis
    Xu, Zhen
    Huang, Zhenhua
    Zhang, Yifan
    Sun, Haitao
    Hinz, Ulf
    Heger, Ulrike
    Loos, Martin
    Gonzalez, Frank J.
    Hackert, Thilo
    Bergmann, Frank
    Fortunato, Franco
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2023, 1869 (07):
  • [27] Molecular tuning of farnesoid X receptor partial agonism
    Merk, Daniel
    Sreeramulu, Sridhar
    Kudlinzki, Denis
    Saxena, Krishna
    Linhard, Verena
    Gande, Santosh L.
    Hiller, Fabian
    Lamers, Christina
    Nilsson, Ewa
    Aagaard, Anna
    Wissler, Lisa
    Dekker, Niek
    Bamberg, Krister
    Schubert-Zsilavecz, Manfred
    Schwalbe, Harald
    NATURE COMMUNICATIONS, 2019, 10 (1)
  • [28] Progress and challenges of selective Farnesoid X Receptor modulation
    Massafra, Vittoria
    Pellicciari, Roberto
    Gioiello, Antimo
    van Mil, Saskia W. C.
    PHARMACOLOGY & THERAPEUTICS, 2018, 191 : 162 - 177
  • [29] Recent Advances in the Medicinal Chemistry of Farnesoid X Receptor
    Fang, Yuanying
    Hegazy, Lamees
    Finck, Brian N.
    Elgendy, Bahaa
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (24) : 17545 - 17571
  • [30] Farnesoid X receptor in the study of fibrosis and its treatments
    Zhao Cong
    Cong Yu-ling
    Xu Yi-jun
    Yin Yan-ru
    CHINESE MEDICAL JOURNAL, 2013, 126 (19) : 3775 - 3781